| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/17/2001 | CA2064473C Chimeric amino acids and peptides containing these analogues |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025410A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 04/12/2001 | WO2001025265A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | WO2001025264A2 Substituted phosphinate based peptide derivatives |
| 04/12/2001 | WO2001025263A1 Solid sweetener compositions, liquid sweetener compositions and utilization thereof |
| 04/12/2001 | WO2001025262A1 Sweetener compositions with high degree of sweetness having improved sweetness, corrigents and utilization thereof |
| 04/12/2001 | WO2001025261A1 Aspartyl dipeptide ester derivatives and sweetening agents |
| 04/12/2001 | WO2001025260A1 Process for the production of aspartyldipeptide ester derivatives, novel intermediates therefor and process for the production of the intermediates |
| 04/12/2001 | WO2001025259A1 Processes for producing and purifying aspartame derivatives and process for producing production intermediates |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001025170A1 N-SUBSTITUTED DIALKYL α-AMINO ACIDS FOR USE AS AMINO PROTECTING GROUPS |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | US20010000231 N- [N- (3,3-dimethylbutyl) -L-alpha-aspartyl] -L- phenylalanine 1-methyl ester agglomerate |
| 04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
| 04/12/2001 | CA2406882A1 Diagnostic probes and therapeutics targeting upa and upar |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2385968A1 Aspartyl dipeptide ester derivatives and sweeteners |
| 04/12/2001 | CA2385767A1 Solid sweetener compositions, liquid sweetener compositions and uses thereof |
| 04/12/2001 | CA2385759A1 Sweetener compositions with a high intense of sweetness having improved sweetness, taste modifier and uses thereof |
| 04/12/2001 | CA2385551A1 Metal-binding compounds and uses therefor |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1090909A1 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 04/11/2001 | EP1090030A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089755A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089750A1 Compositions and methods for inhibiting bone resorption |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291197A Novel acetamide derivative and use thereof |
| 04/10/2001 | US6214861 Enzyme inhibitor; viricides |
| 04/10/2001 | US6214841 Anticoagulants |
| 04/10/2001 | US6214799 Unsaturated amide compounds |
| 04/10/2001 | US6214402 Mixing sugar with water with agitation to form mixture; heating mixture; seeding mixture with premix of n-(n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl)-l-phenylalanine 1-methyl ester or salt; removing from heat; cooling |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | CA2217729C Substance fa-70d, process for producing the same, and uses thereof |
| 04/10/2001 | CA2140543C Thrombin receptor antagonists |
| 04/10/2001 | CA2070421C L-aspartic or l-glutamic acid-derived sweetener and process for its preparation |
| 04/05/2001 | WO2001023413A1 Extracorporeal endotoxin removal method |
| 04/04/2001 | EP1088829A1 Novel aspartyl dipeptide ester derivatives and sweeteners |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1087996A2 Glycosulfopeptides and methods of synthesis and use thereof |
| 04/04/2001 | EP1087991A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/04/2001 | EP1087935A1 Anthracene derivatives as anti-cancer agents |
| 04/04/2001 | EP1075797A9 Novel sweetener compositions |
| 04/04/2001 | EP0741734B1 Phenylboronic acid complexes |
| 04/04/2001 | CN1290268A Nucleosides |
| 04/04/2001 | CN1289779A Process for preparing 1-amidobenzyl 20-aminodicarboxylate |
| 04/03/2001 | US6211427 Peptide production as fusion protein in transgenic mammal milk |
| 04/03/2001 | US6211235 Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 04/03/2001 | US6211183 Selective factor Xa inhibitors |
| 04/03/2001 | US6211176 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/03/2001 | US6211156 Peptides for treatment of erectile dysfunction |
| 04/03/2001 | US6211154 Peptide anticoagulants |
| 03/30/2001 | CA2321379A1 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 03/29/2001 | WO2001021628A1 A substantially cell membrane impermeable compound and use thereof |
| 03/29/2001 | CA2320556A1 N,n-dichlorinated omega amino acids and uses thereof |
| 03/28/2001 | EP1086947A1 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 03/28/2001 | EP1086742A1 Combinatorial strategies for polymer synthesis |
| 03/28/2001 | EP1086122A1 Pyrazinone protease inhibitors |
| 03/28/2001 | EP1086113A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 03/28/2001 | EP1086092A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085869A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 03/28/2001 | EP0779815B1 Surface-modifying copolymers having cell adhesion properties |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | CN1289371A Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications |
| 03/28/2001 | CN1289341A Thrombin inhibitors |
| 03/28/2001 | CN1289340A Alpha, -ketoamide inhibitors of 20s proteasome |
| 03/28/2001 | CN1063760C Plastics containing heat stabilizer of cacylated sucrose |
| 03/28/2001 | CN1063744C 15-deoxyspergulin analogs, their method of preparation and their use in therapeutics |
| 03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
| 03/27/2001 | US6207710 Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | US6207644 Peptide analogues containing a 7-membered lactam ring |
| 03/27/2001 | US6207399 Methods of determining endogenous thrombin potential (ETP) and thrombin substrates for use in said methods |
| 03/27/2001 | US6207391 High-throughput screening assays for modulators of STAT4 and STAT6 activity |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/22/2001 | WO2001019849A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh¿2? |
| 03/22/2001 | WO2001019848A1 Novel processes for the production of peptide compounds |
| 03/22/2001 | WO2001019795A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | WO2001002332A3 Process for the preparation of 3,3-dimethylbutanal |
| 03/22/2001 | WO2000078793A3 Antimicrobial agents |
| 03/22/2001 | CA2384247A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | CA2383184A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 |
| 03/21/2001 | EP1085000A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 03/21/2001 | EP1084409A1 Method and device for electrochemical immunoassay of multiple analytes |
| 03/21/2001 | EP1084140A1 Preparation and purification of a salt of aspartame with acesulfam k |
| 03/21/2001 | EP1084139A1 Preparation of an organic salt of aspartame with acesulfam h |
| 03/21/2001 | EP1084138A1 Method for preparing aspartyl cyclohexylalaninamide |
| 03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |